(E)-2-(1-phenylprop-1-en-2-yl)quinazolin-4(3H)-one

ID: ALA5287753

Max Phase: Preclinical

Molecular Formula: C17H14N2O

Molecular Weight: 262.31

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  C/C(=C\c1ccccc1)c1nc2ccccc2c(=O)[nH]1

Standard InChI:  InChI=1S/C17H14N2O/c1-12(11-13-7-3-2-4-8-13)16-18-15-10-6-5-9-14(15)17(20)19-16/h2-11H,1H3,(H,18,19,20)/b12-11+

Standard InChI Key:  ZVOHTPBIOGUDGJ-VAWYXSNFSA-N

Molfile:  

 
     RDKit          2D

 20 22  0  0  0  0  0  0  0  0999 V2000
    1.7809   -0.6164    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7809   -1.4414    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4887   -1.8520    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2021   -1.4460    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2021   -0.6210    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4942   -0.2020    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0702   -0.2058    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3593   -0.6159    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3593   -1.4367    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3513   -0.2053    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0672   -0.6193    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7764   -0.2035    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7764    0.6218    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0651    1.0313    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3513    0.6199    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0651    1.8520    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4898    1.0303    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2021    0.6218    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2021   -0.2035    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4898   -0.6203    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  1  6  1  0
  1  7  1  0
  7  8  2  0
  8  9  1  0
  8 10  1  0
 11 10  2  0
 12 11  1  0
 13 12  2  0
 13 14  1  0
 10 15  1  0
 15 14  1  0
 14 16  2  0
 13 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 12 20  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5287753

    ---

Associated Targets(Human)

CAL-27 (814 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 262.31Molecular Weight (Monoisotopic): 262.1106AlogP: 3.48#Rotatable Bonds: 2
Polar Surface Area: 45.75Molecular Species: NEUTRALHBA: 2HBD: 1
#RO5 Violations: HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 9.85CX Basic pKa: 4.85CX LogP: 3.53CX LogD: 3.53
Aromatic Rings: 3Heavy Atoms: 20QED Weighted: 0.77Np Likeness Score: -0.47

References

1. Parshuram Satpute D, Shirwadkar U, Kumar Tharalla A, Dattatray Shinde S, Nikhil Vaidya G, Joshi S, Patel Vatsa P, Jain A, Singh AA, Garg R, Mandoli A, Kumar D..  (2023)  Discovery of fluorinated 2‑Styryl 4(3H)-quinazolinone as potential therapeutic hit for oral cancer.,  81  [PMID:36796126] [10.1016/j.bmc.2023.117193]

Source